title: Mesoporous silica nanoparticles facilitate delivery of siRNA to shutdown signaling pathways in mammalian cells.
authors.affiliation: Department of Microbiology, Immunology, and Molecular Genetics California NanoSystems Institute, JCCC University of California, Los Angeles 609 Charles E. Young Drive East, Los Angeles, CA 90095, USA.
authors.forename: Christopher
authors.initials: C
authors.lastname: Hom
authors.forename: Jie
authors.initials: J
authors.lastname: Lu
authors.forename: Monty
authors.initials: M
authors.lastname: Liong
authors.forename: Hanzhi
authors.initials: H
authors.lastname: Luo
authors.forename: Zongxi
authors.initials: Z
authors.lastname: Li
authors.forename: Jeffrey I
authors.initials: JI
authors.lastname: Zink
authors.forename: Fuyuhiko
authors.initials: F
authors.lastname: Tamanoi
mesh_terms: D000818:Animals; D004337:Drug Carriers / Q000737:chemistry*; D020868:Gene Silencing / Q000502:physiology*; D006801:Humans; D008422:Materials Testing; D053758:Nanoparticles / Q000737:chemistry* / Q000648:ultrastructure*; D010316:Particle Size; D016062:Porosity; D034741:RNA, Small Interfering / Q000008:administration & dosage* / Q000235:genetics*; D015398:Signal Transduction / Q000502:physiology*; D012822:Silicon Dioxide / Q000737:chemistry*; D014162:Transfection / Q000379:methods*
chemical_list: D004337:Drug Carriers; D034741:RNA, Small Interfering; D012822:Silicon Dioxide
references.citation: Conf Proc IEEE Eng Med Biol Soc. 2004;2004:3524-6
references.pmid: 17271050
references.citation: Adv Drug Deliv Rev. 2008 Aug 17;60(11):1278-88
references.pmid: 18514969
references.citation: Chem Commun (Camb). 2009 Sep 28;(36):5371-3
references.pmid: 19724788
references.citation: Cancer Res. 1986 Dec;46(12 Pt 1):6387-92
references.pmid: 2946403
references.citation: Int J Biol Macromol. 2005 Dec 30;37(5):283-6
references.pmid: 16405995
references.citation: J Am Chem Soc. 2004 Oct 20;126(41):13216-7
references.pmid: 15479063
references.citation: Gene Ther. 1999 Aug;6(8):1380-8
references.pmid: 10467362
references.citation: Adv Drug Deliv Rev. 2001 Dec 31;53(3):341-58
references.pmid: 11744176
references.citation: Mol Pharm. 2009 May-Jun;6(3):727-37
references.pmid: 19178144
references.citation: Small. 2009 Jan;5(1):57-62
references.pmid: 19051185
references.citation: ACS Nano. 2009 Oct 27;3(10):3273-86
references.pmid: 19739605
references.citation: Nano Lett. 2009 Jan;9(1):442-8
references.pmid: 19099455
references.citation: Expert Rev Anticancer Ther. 2008 Aug;8(8):1331-8
references.pmid: 18699769
references.citation: Crit Rev Oncol Hematol. 2004 Apr;50(1):51-70
references.pmid: 15094159
references.citation: J Phys Chem B. 2009 Feb 12;113(6):1796-804
references.pmid: 19152258
references.citation: Nature. 2009 Jan 22;457(7228):426-33
references.pmid: 19158789
references.citation: Eur J Pharm Biopharm. 2004 Jul;58(1):1-6
references.pmid: 15207531
references.citation: Int J Pharm. 2000 Mar 10;196(2):257-61
references.pmid: 10699731
references.citation: Small. 2007 Aug;3(8):1341-6
references.pmid: 17566138
references.citation: Anal Chem. 2008 Dec 15;80(24):9597-603
references.pmid: 19007246
references.citation: Nat Rev Cancer. 2009 Aug;9(8):550-62
references.pmid: 19629070
references.citation: Biomaterials. 2010 Jan;31(3):438-48
references.pmid: 19800115
references.citation: J Control Release. 2008 Nov 24;132(1):55-64
references.pmid: 18727943
references.citation: Nanoscale. 2009 Oct;1(1):16-39
references.pmid: 20644858
references.citation: Clin Cancer Res. 2005 Jun 15;11(12):4487-94
references.pmid: 15958634
references.citation: Gene Ther. 2000 Jul;7(13):1148-55
references.pmid: 10918482
references.citation: Proc Natl Acad Sci U S A. 1995 Aug 1;92(16):7297-301
references.pmid: 7638184
references.citation: Org Lett. 2006 Jul 20;8(15):3363-6
references.pmid: 16836406
references.citation: Gene Ther. 2006 Aug;13(15):1131-2
references.pmid: 17243201
references.citation: Clin Cancer Res. 1999 Jan;5(1):7-8
references.pmid: 9918196
references.citation: Small. 2008 Apr;4(4):421-6
references.pmid: 18383576
references.citation: ACS Nano. 2008 May;2(5):889-96
references.pmid: 19206485
references.citation: J Am Ceram Soc. 2009 Jan 1;92(s1):s2-s10
references.pmid: 19834571
references.citation: J Am Chem Soc. 2008 Feb 27;130(8):2382-3
references.pmid: 18232687
references.citation: Nano Lett. 2008 Sep;8(9):3069-74
references.pmid: 18698730
references.citation: ACS Nano. 2008 Nov 25;2(11):2324-30
references.pmid: 19206399
references.citation: Mol Ther. 2005 Apr;11(4):523-30
references.pmid: 15771955
references.citation: Adv Drug Deliv Rev. 2002 Sep 13;54(5):715-58
references.pmid: 12204600
references.citation: J Am Chem Soc. 2003 Apr 16;125(15):4451-9
references.pmid: 12683815
references.citation: J Am Chem Soc. 2006 Nov 22;128(46):14792-3
references.pmid: 17105274
references.citation: Methods Mol Biol. 2009;544:547-57
references.pmid: 19488722
references.citation: Nat Nanotechnol. 2007 May;2(5):295-300
references.pmid: 18654287
references.citation: Nanobiotechnology. 2007 May 1;3(2):89-95
references.pmid: 19936038
references.citation: Int J Pharm. 2008 Jul 9;359(1-2):280-7
references.pmid: 18490119